Skip to main content
. 2009 Jun;7(1-2):21–31. doi: 10.3121/cmr.2009.819

Table 1.

Demographic and clinical characteristics (n=20).

Number of patients (%)
Severity of edema*
    None 4 (20)
    Mild 10 (50)
    Moderate 3 (15)
    Severe 3 (15)
Type of edema
    Venous stasis 10 (50)
    Lipedema 4 (20)
    Lymphedema 1 (5)
    Two or more 2 (10)
    None 3 (15)
Mean age, years (range) 70.2 (59 to 85)
Gender, women 14 (70)
Race, white 20 (100)
Mean weight, kg (range) 91.8 (59.4 to 133.4)
Mean body mass index (kg/m2 ) 33.1 (20.8 to 45.8)
Concurrent conditions
    Hypertension 17 (85)
    Dyslipidemia/hyperlipidemia 17 (85)
    Coronary artery disease 6 (30)
    Chronic heart failure 4 (20)
    Dyspnea 2 (10)
    Venous insufficiency 1 (5)
    Renal insufficiency 4 (20)
    Arthritis 6 (30)
Concomitant medications§
    Anti-hypertensive medication, excluding diuretics 18 (90)
    Diuretics 14 (70)
    Lipid-altering medication 9 (45)
    Non-steroidal anti-inflammatory agents 2 (10)
    Thiazolidinediones 1 (5)
    Insulin 7 (35)

* Initial classification of edema was determined by a physician and based upon the classic clinical assessment of edema. Efforts were made to recruit patients with a range of edema severity and patients with no edema.

One patient was classified as having a medical history of edema consistent with lipedema but no edema was present at the time of the study.

Lipedema is a entity distinguished clinically from lymphedema by the presence of soft symmetrical tissue enlargement of the lower extremities with sparing of the foot, ankle and upper extremities.[1]

§ Medications taken on the day of the visit.